Improving the effectiveness of lifestyle interventions for gestational diabetes prevention: a meta-analysis and meta-regression 30216635 2018 10 25 1471-0528 2018 Sep 14 BJOG : an international journal of obstetrics and gynaecology BJOG Improving the effectiveness of lifestyle interventions for gestational diabetes prevention: a meta-analysis and meta-regression. 10.1111/1471-0528.15467 Diet and exercise during pregnancy have been used to prevent gestational diabetes mellitus (GDM) with some (...) 2018 09 14 England BJOG 100935741 1470-0328 Effectiveness gestational diabetes mellitus lifestyle intervention meta-analysis meta-regression prevention 2018 08 29 2018 9 15 6 0 2018 9 15 6 0 2018 9 15 6 0 aheadofprint 30216635 10.1111/1471-0528.15467

Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 29859136 2018 09 01 1097-6868 219 3 2018 Sep American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. 300.e1-300.e6 S0002-9378(18)30428-9 10.1016/j.ajog.2018.05.018 (...) Gestational diabetes mellitus is defined as carbohydrate intolerance that begins or is first recognized during pregnancy. Insulin sensitizing substances such as myo-inositol have been considered for the prevention of gestational diabetes mellitus and related complications. Because previous studies failed to show a clear reduction of gestational diabetes mellitus complications, the aim of this study was to evaluate clinical and metabolic outcomes in women who are at risk for gestational diabetes mellitus

A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational Diabetes 30302420 2018 11 14 2472-1972 2 10 2018 Oct 01 Journal of the Endocrine Society J Endocr Soc A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational Diabetes. 1158-1169 10.1210/js.2018-00200 Previous studies have not examined the ability of multiple preconception biomarkers, considered together, to improve prediction of gestational diabetes mellitus (GDM). To develop a preconception (...) , Oakland, California. Ehrlich Samantha F SF Division of Research, Kaiser Permanente Northern California, Oakland, California. University of Tennessee Knoxville, Knoxville, Tennessee. Quesenberry Charles P CP Division of Research, Kaiser Permanente Northern California, Oakland, California. Hedderson Monique M MM Division of Research, Kaiser Permanente Northern California, Oakland, California. eng Journal Article 2018 09 13 United States J Endocr Soc 101697997 2472-1972 biomarker gestational diabetes pre

Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity. Importance: The sequelae of gestational diabetes (GD) by contemporary criteria that diagnose approximately twice as many women as previously used criteria are unclear. Objective: To examine associations of GD with maternal glucose metabolism and childhood adiposity 10 to 14 years' postpartum. Design, Setting, and Participants: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study (...) established associations of glucose levels during pregnancy with perinatal outcomes and the follow-up study evaluated the long-term outcomes (4697 mothers and 4832 children; study visits occurred between February 13, 2013, and December 13, 2016). Exposures: Gestational diabetes was defined post hoc using criteria from the International Association of Diabetes and Pregnancy Study Groups consisting of 1 or more of the following 75-g oral glucose tolerance test results (fasting plasma glucose ≥92 mg/dL; 1

Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. BACKGROUND: Successful treatments for gestational diabetes mellitus (GDM) have the potential to improve health outcomes for women with GDM and their babies. OBJECTIVES: To provide a comprehensive synthesis of evidence from Cochrane systematic reviews of the benefits and harms associated with interventions for treating GDM on women and their babies. METHODS: We searched the Cochrane Database (...) (hypoglycaemia); metformin versus glibenclamide (hypertensive disorders of pregnancy, pregnancy-induced hypertension, death or serious morbidity composite, insulin versus oral therapy (development of type 2 diabetes); intensive management versus routine care (IOL, large-for-gestational age); post- versus pre-prandial glucose monitoring (large-for-gestational age). The evidence ranged from moderate-, low- and very low-quality. AUTHORS' CONCLUSIONS: Currently there is insufficient high-quality evidence about

Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes 29730938 2018 06 07 1535-7228 175 6 2018 Jun 01 The American journal of psychiatry Am J Psychiatry Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. 564-574 10.1176/appi.ajp.2018.17040393 Some atypical antipsychotics are associated with metabolic side effects, which are risk factors for gestational diabetes. The authors (...) examined the risk of developing gestational diabetes associated with the continuation of treatment with aripiprazole, ziprasidone, quetiapine, risperidone, and olanzapine during pregnancy compared with discontinuation of these antipsychotic drugs. Nondiabetic pregnant women who were linked to a live-born infant and enrolled in Medicaid (2000-2010) and who received one or more prescriptions dispensed for an antipsychotic drug during the 3 months before pregnancy were included in the analyses. Among

Gestational Diabetes © 2002 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Gestational Diabetes Screening and Treatment Guideline Major Changes as of April 2018 2 Screening Recommendations and Tests 2 Diagnosis 3 Treatment Goals 3 Lifestyle modifications/non-pharmacologic options 3 Pharmacologic options 4 Additional Testing/Monitoring Antenatal monitoring 7 Follow-up after delivery 7 Referral 7 Evidence Summary 8 References 11 Guideline Development Process and Team 12 Last (...) in the guidelines may not be appropriate for use in all circumstances. The inclusion of a recommendation in a guideline does not imply coverage. A decision to adopt any particular recommendation must be made by the provider in light of the circumstances presented by the individual patient. 2 Major Changes as of April 2018 New Previous 2-step gestational diabetes (GDM) screening test 1-step GDM screening test Follow Canadian Diabetes Association blood glucose cutoffs for diagnosis: • Fasting = 95 mg/dL or • 1

Gestational diabetes Top results for gestational diabetes - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box (...) and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for gestational diabetes The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews

Gestational diabetes Autosynthesis - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search

Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight 29934478 2018 06 23 1935-5548 41 7 2018 07 Diabetes care Diabetes Care Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal (...) Birth Weight. 1346-1361 10.2337/dc18-0102 Medical nutrition therapy is a mainstay of gestational diabetes mellitus (GDM) treatment. However, data are limited regarding the optimal diet for achieving euglycemia and improved perinatal outcomes. This study aims to investigate whether modified dietary interventions are associated with improved glycemia and/or improved birth weight outcomes in women with GDM when compared with control dietary interventions. Data from published randomized controlled trials

Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial 29663517 2018 05 23 1464-5491 2018 Apr 16 Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. Continuous glucose monitoring results in lower HbA 1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial. 10.1111/dme.13649 To determine if therapeutic, retrospective continuous glucose (...) monitoring (CGM) improves HbA 1c with less hypoglycaemia in women with insulin-treated gestational diabetes mellitus (GDM). This prospective, randomized controlled, open-label trial evaluated 50 women with insulin-treated GDM randomized to either retrospective CGM (6-day sensor) at 28, 32 and 36 weeks' gestation (Group 1, CGM, n = 25) or usual antenatal care without CGM (Group 2, control, n = 25). All women performed seven-point capillary blood glucose (CBG) profiles at least 3 days per week and recorded

A Tailored Letter Based on Electronic Health Record Data Improves Gestational Weight Gain Among Women With Gestational Diabetes: The Gestational Diabetes` Effects on Moms (GEM) Cluster-Randomized Controlled Trial 29669736 2018 04 19 1935-5548 2018 Apr 18 Diabetes care Diabetes Care A Tailored Letter Based on Electronic Health Record Data Improves Gestational Weight Gain Among Women With Gestational Diabetes: The Gestational Diabetes' Effects on Moms (GEM) Cluster-Randomized Controlled Trial (...) . dc171133 10.2337/dc17-1133 Evaluate whether a tailored letter improved gestational weight gain (GWG) and whether GWG mediated a multicomponent intervention's effect on postpartum weight retention among women with gestational diabetes mellitus (GDM). A cluster-randomized controlled trial of 44 medical facilities ( n = 2,014 women) randomized to usual care or a multicomponent lifestyle intervention delivered during pregnancy (tailored letter) and postpartum (13 telephone sessions) to reduce postpartum

Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study 29498473 2018 03 26 1463-1326 2018 Mar 02 Diabetes, obesity & metabolism Diabetes Obes Metab Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study. 10.1111/dom.13275 To evaluate the association between use of non-insulin antidiabetics in early pregnancy and the risk of miscarriages, stillbirths and major structural malformations (...) . A cohort of 1511 pregnant women with pre-gestational diabetes linked to live births was identified using electronic medical records from The Health Improvement Network (THIN) for the period 1995 to 2012. Information on prescriptions, foetal outcomes and potential confounders was ascertained from both codes and free text in the THIN database. Odds ratios (OR) and 95% confidence intervals (CI) of adverse foetal outcomes in women treated with non-insulin antidiabetics during the first trimester compared

Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial. Importance: Randomized trials have not focused on neonatal complications of glyburide for women with gestational diabetes. Objective: To compare oral glyburide vs subcutaneous insulin in prevention of perinatal complications in newborns of women with gestational diabetes. Design, Settings, and Participants: The Insulin Daonil trial (INDAO), a multicenter (...) noninferiority randomized trial conducted between May 2012 and November 2016 (end of participant follow-up) in 13 tertiary care university hospitals in France including 914 women with singleton pregnancies and gestational diabetes diagnosed between 24 and 34 weeks of gestation. Interventions: Women who required pharmacologic treatment after 10 days of dietary intervention were randomly assigned to receive glyburide (n=460) or insulin (n=454). The starting dosage for glyburide was 2.5 mg orally once per day

Gestational Diabetes Mellitus Sign In (ACOG) Sign in to your ACOG account Email is required. Please enter valid Email. was not found in our system. Would you like to associated with your account? Forgot your email address? JSOG Member? © 2018 - American College of Obstetricians and Gynecologists

The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial 29425836 2018 03 30 1097-6868 218 4 2018 Apr American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled (...) trial. 453.e1-453.e7 S0002-9378(18)30133-9 10.1016/j.ajog.2018.01.044 Patient compliance and tight glycemic control have been demonstrated to improve outcome in pregnancies complicated by gestational diabetes mellitus. The use of advanced technological tools, including smartphone-based platforms, to improve medical care and outcomes has been demonstrated in various fields of medicine, but only a few small studies were performed with gestational diabetes mellitus patients. We aimed to study

Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect 29244241 2018 01 22 1471-0528 2017 Dec 15 BJOG : an international journal of obstetrics and gynaecology BJOG Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect. 10.1111/1471-0528.15060 Gestational diabetes mellitus (GDM) is an increasingly prevalent disorder, associated with low blood vitamin D level. To evaluate the relationship between (...) the risk of GDM, and vitamin D supplementation during pregnancy could ameliorate the condition of GDM. Low blood vitamin D increases gestational diabetes mellitus (GDM) risk. Vitamin D supplementation ameliorates GDM condition. © 2017 Royal College of Obstetricians and Gynaecologists. Zhang Y Y Department of Nutrition, Food Safety and Toxicology, West China School of Public Health, Sichuan University, Chengdu, China. School of Public Health, Tongji Medical College, Huazhong University of Science

Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. BACKGROUND: Gestational diabetes is a type of diabetes that occurs during pregnancy. Women with gestational diabetes are more likely to experience adverse health outcomes such as pre-eclampsia or polyhydramnios (excess amniotic fluid). Their babies are also more likely to have health complications such as macrosomia (birthweight > 4000 g) and being large-for-gestational (...) age (birthweight above the 90th percentile for gestational age). Current clinical guidelines support elective birth, at or near term in women with gestational diabetes to minimise perinatal complications, especially those related to macrosomia.This review replaces a review previously published in 2001 that included "diabetic pregnant women", which has now been split into two reviews. This current review focuses on pregnant women with gestational diabetes and a sister review focuses on women

Gestational diabetes mellitus Gestational diabetes mellitus - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Gestational diabetes mellitus Last reviewed: August 2018 Last updated: April 2018 Summary Develops during pregnancy and is usually diagnosed at 24 to 28 weeks of gestation on the basis of elevated plasma glucose levels on glucose tolerance testing. Goal of therapy is to achieve maternal glucose levels (...) that are as close to normal as possible in order to avoid fetal macrosomia and complications. Initial therapy for gestational diabetes is usually dietary modification. Insulin is started when acceptable glucose levels cannot be maintained with diet alone. Maternal postnatal testing for diabetes or impaired glucose tolerance is performed at least 6 weeks following delivery. The risk for recurrence of GDM in subsequent pregnancies or progression to type 2 diabetes is high. Definition Gestational diabetes mellitus

Comparison of umbilical artery Doppler and non-stress test in assessment of fetal well-being in gestational diabetes mellitus: A prospective cohort study Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir December 2017, Volume: 9, Issue: 12, Pages: 6087-6093, DOI: http://dx.doi.org/10.19082/6087 Corresponding author: Assistant Professor Dr. Mitra Eftekhariyazdi, Department of Obstetrics & Gynecology, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran. Tel (...) , provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Page 6087 Comparison of umbilical artery Doppler and non-stress test in assessment of fetal well-being in gestational diabetes mellitus: A prospective cohort study Shirin Niromanesh 1 , Mahboobeh shirazi 1,2 , Mitra Eftekhariyazdi 3 , Forough Mortazavi 4 1 Perinatologist, Professor, Maternal, Fetal and Neonatal Research Center, Women Hospital, Tehran University of Medical Sciences